Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction

被引:372
|
作者
Ho, Tin-Yun
Wu, Shih-Lu
Chen, Jaw-Chyun
Li, Chia-Cheng
Hsiang, Chien-Yun
机构
[1] China Med Univ, Dept Microbiol, Taichung 404, Taiwan
[2] China Med Univ, Grad Inst Chinese Pharmaceut, Taichung 404, Taiwan
[3] China Med Univ, Dept Biochem, Taichung 404, Taiwan
[4] China Med Univ, Mol Biol Lab, Grad Inst Chinese Med Sci, Taichung 404, Taiwan
关键词
SARS coronavirus; spike protein; angiotensin-converting enzyme 2; emodin;
D O I
10.1016/j.antiviral.2006.04.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a novel coronavirus (SARS-CoV). SARS-CoV spike (S) protein, a type I membrane-bound protein, is essential for the viral attachment to the host cell receptor angiotensin-converting enzyme 2 (ACE2). By screening 312 controlled Chinese medicinal herbs supervised by Committee on Chinese Medicine and Pharmacy at Taiwan, we identified that three widely used Chinese medicinal herbs of the family Polygonaceae inhibited the interaction of SARS-CoV S protein and ACE2. The IC50 values for Radix et Rhizoma Rhei (the root tubers of Rheum officinale Baill.), Radix Polygoni multiflori (the root tubers of Polygonum multiflorum Thunb.), and Caulis Polygom multiflori (the vines of P. multiflorum Thunb.) ranged from I to 10 [Lg/ml. Emodin, an anthraquinone compound derived from genus Rheum and Polygonum, significantly blocked the S protein and ACE2 interaction in a dose-dependent manner. It also inhibited the infectivity of S protein-pseudotyped retrovirus to Vero E6 cells. These findings suggested that emodin may be considered as a potential lead therapeutic agent in the treatment of SARS. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:92 / 101
页数:10
相关论文
共 50 条
  • [41] EXPRESSION OF ANGIOTENSIN-CONVERTING ENZYME AND ANGIOTENSIN-CONVERTING ENZYME 2 IN PATIENTS WITH CHRONIC HEART FAILURE
    Wang, Jiang
    Li, Nan
    Li, Ai-min
    Song, Rong
    Gao, Feng
    Geng, Zhao-Hua
    HEART, 2011, 97 : A52 - A52
  • [42] Conversion of Aβ43 to Aβ40 by the Successive Action of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme
    Liu, Shuyu
    Liu, Junjun
    Miura, Yukie
    Tanabe, Chiaki
    Maeda, Tomoji
    Terayama, Yasuo
    Turner, Anthony J.
    Zou, Kun
    Komano, Hiroto
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (09) : 1178 - 1186
  • [43] Expression of angiotensin-converting enzyme and angiotensin-converting enzyme 2 in patients with chronic heart failure
    Wang, Jiang
    Li, Nan
    Li, Ai-min
    Song, Rong
    Gao, Feng
    Geng, Zhao-Hua
    Zhu, Shan-Jun
    CARDIOLOGY, 2011, 120 : 27 - 27
  • [44] Angiotensin-Converting Enzyme 2 Activation Is Not a Common Feature of Angiotensin-Converting Enzyme Inhibitory Peptides
    Wang, Zihan
    Fan, Hongbing
    Bao, Xiaoyu
    Wu, Jianping
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (23) : 8867 - 8876
  • [45] Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers
    Sarzani, Riccardo
    Giulietti, Federico
    Di Pentima, Chiara
    Giordano, Piero
    Spannella, Francesco
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (16) : E10 - E13
  • [46] Angiotensin-Converting Enzyme 2 Genetic Variants Are Associated With Coronavirus Disease 2019
    Pati, Abhijit
    Padhi, Sunali
    Nayak, Tapan Kumar Singh
    Panda, Aditya K.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (12): : 2181 - 2183
  • [47] Angiotensin-converting enzyme 2 as a versatile player in the management of coronavirus disease 2019
    Amano, Tetsuya
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (05) : 1120 - 1122
  • [48] Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019
    Suh, Sang Heon
    Ma, Seong Kwon
    Kim, Soo Wan
    Bae, Eun Hui
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (02): : 247 - 262
  • [49] Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
    Batlle, Daniel
    Wysocki, Jan
    Satchell, Karla
    CLINICAL SCIENCE, 2020, 134 (05) : 543 - 545
  • [50] Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms
    Xu, Baohui
    Li, Gang
    Guo, Jia
    Ikezoe, Toru
    Kasirajan, Karthikeshwar
    Zhao, Sihai
    Dalman, Ronald L.
    JOURNAL OF VASCULAR SURGERY, 2021, 74 (05) : 1740 - 1751